What the limitations and caveats are *These are observational studies, not randomized controlled trials specifically powered to examine vision-loss risk
Although guidelines suggest cautious use in compensated cirrhosis and avoidance in decompensated liver disease, a large retrospective cohort study found no significant drug-induced liver injury from naltrexone and no attributed decompensations, supporting its use in both compensated and decompensated cirrhosis with close monitoring [120,121]
Dihexa is reported to be active at picomolar concentrations in synaptogenesis assaysapproximately 10,00010,000,000-fold more potent than BDNF (brain-derived neurotrophic factor) in some in vitro measures, though this comparison involves different assay conditions and should not be taken as a direct clinical equivalence claim
Moreover, negative media coverage or reports of adverse events can lead to increased scrutiny from regulatory bodies and public hesitation, hindering acceptance in the mainstream healthcare setting
Natural and synthetic thymic peptides as therapeutics for immune dysfunction
Patients should be aware of symptoms such as severe abdominal pain, an inability to pass gas, or difficulty moving bowels and seek immediate medical attention if these occur